Connor, Clark & Lunn Investment Management (CC&L)
CDMO

Connor, Clark & Lunn Investment Management (CC&L)’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30,625
Closed -$235K – 1198
2019
Q4 		$235K Buy
+30,625
New +$179K ﹤0.01% 811
2019
Q2 		– Sell
-19,236
Closed -$82K – 1089
2019
Q1 		$82K Sell
19,236
-10,300
-35% -$42K ﹤0.01% 878
2018
Q4 		$121K Sell
29,536
-16,730
-36% -$87.3K ﹤0.01% 893
2018
Q3 		$317K Buy
46,266
+19,246
+71% +$114K ﹤0.01% 778
2018
Q2 		$106K Sell
27,020
-38,575
-59% -$134K ﹤0.01% 995
2018
Q1 		$192K Buy
+65,595
New +$203K ﹤0.01% 659
2017
Q4 		– Sell
-98,772
Closed -$310K – 866
2017
Q3 		$310K Buy
+98,772
New +$371K ﹤0.01% 703
2017
Q2 		– Sell
-9,989
Closed -$46K – 976
2017
Q1 		$46K Buy
+9,989
New +$33.5K ﹤0.01% 874

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CDMO Position: Q1 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2020, closing a stake of 30,625 shares — an estimated $235K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CDMO in Q1 2017 and held it in 8 quarters. The position peaked at $317K in Q3 2018. 98 funds tracked by Wall St. Rank hold CDMO as of Q1 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 30,625 Avid Bioservices, Inc. Common Stock shares in Q1 2020, an estimated $235K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2017 and held it in 8 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Avid Bioservices, Inc. Common Stock position peaked at $317K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2020, filed 13 May 2020.